Pathomechanism of dupilumab-associated inflammatory eye symptoms

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e435-e436. doi: 10.1111/jdv.15755. Epub 2019 Jul 3.

Authors

J Wohlrab^{1

2}, T Werfel³, A Wollenberg⁴

Affiliations

¹ Department of Dermatology and Venereology, Martin Luther University Halle-Wittenberg, Halle, Germany.
² Institute of Applied Dermatopharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany.
³ Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
⁴ Department of Dermatology and Allergy, Ludwig Maximillian University, Munich, Germany.

PMID: 31220376
DOI: 10.1111/jdv.15755

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Blepharitis / chemically induced*
Conjunctivitis / chemically induced*
Dermatitis, Atopic / drug therapy*
Humans
Interleukin-4 Receptor alpha Subunit / drug effects*
Keratitis / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Interleukin-4 Receptor alpha Subunit
dupilumab